Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cabanillas

Showing results (1-10 of 321) with videos related to

Pageof 33
Sort By:
Seminars in Oncology|February 1, 1989
Experience with ifosfamide combinations in malignant lymphomasF Cabanillas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 1999
Can we cure indolent lymphomas?F Cabanillas
Pathologie-Biologie|January 1, 1993
Front line management of intermediate grade lymphomas at M.D. Anderson HospitalF Cabanillas
Oncology (Williston Park, N.Y.)|July 11, 2000
Purine nucleoside analogs in indolent non-Hodgkin's lymphomaF Cabanillas
Hematological Oncology|July 1, 1988
A review and interpretation of cytogenetic abnormalities identified in Hodgkin's diseaseF Cabanillas
Seminars in Hematology|January 6, 2000
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphomaF Cabanillas
Seminars in Oncology|April 1, 1990
Ifosfamide combinations in lymphomaF Cabanillas
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
To CHOP or not to CHOP ... is that the question?F Cabanillas
The New England Journal of Medicine|February 12, 1998
Granulocyte colony-stimulating factor in afebrile patients with neutropeniaF Cabanillas
Seminars in Oncology|February 1, 1992
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experienceF Cabanillas
Pageof 33

Showing results (1-10 of 321) with videos related to

Sort By:
Pageof 33
Seminars in Oncology|February 1, 1989
Experience with ifosfamide combinations in malignant lymphomasF Cabanillas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 1999
Can we cure indolent lymphomas?F Cabanillas
Pathologie-Biologie|January 1, 1993
Front line management of intermediate grade lymphomas at M.D. Anderson HospitalF Cabanillas
Oncology (Williston Park, N.Y.)|July 11, 2000
Purine nucleoside analogs in indolent non-Hodgkin's lymphomaF Cabanillas
Hematological Oncology|July 1, 1988
A review and interpretation of cytogenetic abnormalities identified in Hodgkin's diseaseF Cabanillas
Seminars in Hematology|January 6, 2000
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphomaF Cabanillas
Seminars in Oncology|April 1, 1990
Ifosfamide combinations in lymphomaF Cabanillas
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
To CHOP or not to CHOP ... is that the question?F Cabanillas
The New England Journal of Medicine|February 12, 1998
Granulocyte colony-stimulating factor in afebrile patients with neutropeniaF Cabanillas
Seminars in Oncology|February 1, 1992
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experienceF Cabanillas
Pageof 33